BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2126 related articles for article (PubMed ID: 18772053)

  • 21. Region-dependent regulation of mesoaccumbens dopamine neurons in vivo by the constitutive activity of central serotonin2C receptors.
    Navailles S; Moison D; Ryczko D; Spampinato U
    J Neurochem; 2006 Nov; 99(4):1311-9. PubMed ID: 17018023
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of dorsal raphe neurons in paradoxical sleep generation in the cat: no evidence for a serotonergic mechanism.
    Sakai K; Crochet S
    Eur J Neurosci; 2001 Jan; 13(1):103-12. PubMed ID: 11135008
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Involvement of 5-HT1B receptors within the ventral tegmental area in ethanol-induced increases in mesolimbic dopaminergic transmission.
    Yan QS; Zheng SZ; Feng MJ; Yan SE
    Brain Res; 2005 Oct; 1060(1-2):126-37. PubMed ID: 16212943
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The acute and chronic administration of the 5-HT(2B/2C) receptor antagonist SB-200646A significantly alters the activity of spontaneously active midbrain dopamine neurons in the rat: An in vivo extracellular single cell study.
    Blackburn TP; Suzuki K; Ashby CR
    Synapse; 2006 Jun; 59(8):502-12. PubMed ID: 16565966
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of local microinjection of selective dopamine D1 and D2 receptor agonists and antagonists into the dorsal raphe nucleus on sleep and wakefulness in the rat.
    Monti JM; Jantos H
    Behav Brain Res; 2018 Feb; 339():11-18. PubMed ID: 29137945
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 5-HT1A and 5-HT1B receptor agonists and aggression: a pharmacological challenge of the serotonin deficiency hypothesis.
    de Boer SF; Koolhaas JM
    Eur J Pharmacol; 2005 Dec; 526(1-3):125-39. PubMed ID: 16310183
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of the 5-HT1A receptor ligands flesinoxan and WAY 100635 given systemically or microinjected into the laterodorsal tegmental nucleus on REM sleep in the rat.
    Monti JM; Jantos H
    Behav Brain Res; 2004 May; 151(1-2):159-66. PubMed ID: 15084431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blockade of the NMDA and AMPA/kainate receptors in the dorsal raphe nucleus prevents the 5-HT₃ receptor agonist m-chlorophenylbiguanide-induced suppression of REM sleep in the rat.
    Monti JM; Jantos H; Catenaccio V; Xavier S
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jul; 35(5):1341-8. PubMed ID: 21514352
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Agonist and antagonist actions of yohimbine as compared to fluparoxan at alpha(2)-adrenergic receptors (AR)s, serotonin (5-HT)(1A), 5-HT(1B), 5-HT(1D) and dopamine D(2) and D(3) receptors. Significance for the modulation of frontocortical monoaminergic transmission and depressive states.
    Millan MJ; Newman-Tancredi A; Audinot V; Cussac D; Lejeune F; Nicolas JP; Cogé F; Galizzi JP; Boutin JA; Rivet JM; Dekeyne A; Gobert A
    Synapse; 2000 Feb; 35(2):79-95. PubMed ID: 10611634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intracerebroventricular administration of NMDA-R1 antisense oligodeoxynucleotide significantly alters the activity of ventral tegmental area dopamine neurons: an electrophysiological study.
    Tajiri K; Emori K; Murata M; Tanaka K; Suzuki M; Uehara T; Sumiyoshi T; Ashby CR; Kurachi M
    Synapse; 2001 Jun; 40(4):275-81. PubMed ID: 11309843
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sleep-waking discharge profiles of dorsal raphe nucleus neurons in mice.
    Sakai K
    Neuroscience; 2011 Dec; 197():200-24. PubMed ID: 21958868
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Parkinson's disease--opportunities for novel therapeutics to reduce the problems of levodopa therapy.
    Fox SH; Chuang R; Brotchie JM
    Prog Brain Res; 2008; 172():479-94. PubMed ID: 18772047
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of dorsal raphe nucleus serotonin 5-HT1A receptor in the regulation of REM sleep.
    Monti JM; Monti D
    Life Sci; 2000 Apr; 66(21):1999-2012. PubMed ID: 10823340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization and mapping of sleep-waking specific neurons in the basal forebrain and preoptic hypothalamus in mice.
    Takahashi K; Lin JS; Sakai K
    Neuroscience; 2009 Jun; 161(1):269-92. PubMed ID: 19285545
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dorsal raphe nucleus administration of 5-HT1A receptor agonist and antagonists: effect on rapid eye movement sleep in the rat.
    Monti JM; Jantos H; Monti D; Alvariño F
    Sleep Res Online; 2000; 3(1):29-34. PubMed ID: 11382897
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serotonin neurons and sleep. I. Long term recordings of dorsal raphe discharge frequency and PGO waves.
    Lydic R; McCarley RW; Hobson JA
    Arch Ital Biol; 1987 Oct; 125(4):317-43. PubMed ID: 3439827
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 5-HT2 receptors differentially modulate dopamine-mediated auto-inhibition in A9 and A10 midbrain areas of the rat.
    Olijslagers JE; Werkman TR; McCreary AC; Siarey R; Kruse CG; Wadman WJ
    Neuropharmacology; 2004 Mar; 46(4):504-10. PubMed ID: 14975674
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Electrophysiological impact of trazodone on the dopamine and norepinephrine systems in the rat brain.
    Ghanbari R; El Mansari M; Blier P
    Eur Neuropsychopharmacol; 2012 Jul; 22(7):518-26. PubMed ID: 22154666
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sleep suppressant action of fenfluramine in rats. I. Relation to postsynaptic serotonergic stimulation.
    Fornal C; Radulovacki M
    J Pharmacol Exp Ther; 1983 Jun; 225(3):667-74. PubMed ID: 6683311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Melanin-concentrating hormone control of sleep-wake behavior.
    Monti JM; Torterolo P; Lagos P
    Sleep Med Rev; 2013 Aug; 17(4):293-8. PubMed ID: 23477948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 107.